Trend of the Month Rapamycin & the rise of longevity medicine Read more
How to Source GLP-1s for Your Clinic Legally in 2026

How to Source GLP-1s for Your Clinic Legally in 2026

How to Source GLP-1s for Your Clinic Legally in 2026Nova S.
Published on: 08/09/2026

How weight loss clinics can legally source GLP-1s in 2026 — branded product through authorized distributors, narrow 503A patient-specific compounding, IRB-governed studies, and why gray-market sourcing is not an option.

how to source GLP-1 for clinicGLP-1 sourcing clinicbranded semaglutide clinic supplyweight loss clinic pharmacy sourcingGLP-1 gray market riskclinic GLP-1 supplierauthorized distributor GLP-1503A patient specific compoundingIRB study GLP-1 sourcingWegovy Zepbound clinic supplycompounded GLP-1 compliance
Read more
How Much Do TRT Clinics Make? A Revenue Breakdown for 2026

How Much Do TRT Clinics Make? A Revenue Breakdown for 2026

How Much Do TRT Clinics Make? A Revenue Breakdown for 2026Nova S.
Published on: 25/08/2026

How much TRT clinics make in 2026 — unit economics, the two revenue streams, patient lifetime value, breakeven patient volume, and what actually drives profitability differences between clinics.

how much do TRT clinics makeTRT clinic revenuehormone clinic profit marginstestosterone clinic incomeTRT clinic patient lifetime valuehormone clinic profitability 2026
Read more
Stem Cell Clinic vs. Franchise: What the R3 Stem Cell Enforcement History Actually Teaches Independent Owners

Stem Cell Clinic vs. Franchise: What the R3 Stem Cell Enforcement History Actually Teaches Independent Owners

Stem Cell Clinic vs. Franchise: What the R3 Stem Cell Enforcement History Actually Teaches Independent OwnersNova S.
Published on: 23/07/2026

Stem cell clinic franchise versus independent ownership in 2026 — what the R3 Stem Cell FDA enforcement history reveals about network model compliance risk, and what independent ownership actually protects against.

stem cell clinic franchise vs independentR3 Stem Cell alternativestem cell clinic network modelindependent stem cell clinicstem cell franchise riskstem cell clinic brand ownershipR3 Stem Cell FDA warning letterstem cell clinic network compliance riskindependent stem cell clinic ownershipstem cell affiliate clinic exposurestem cell brand licensing riskshould I join a stem cell clinic network or go independentR3 Stem Cell FDA history · stem cell clinic franchise alternative 2026
Read more
Supplier Access for Regenerative Health Clinics: Why the Vendor Relationships You Have on Day One Determine Your Margins for Years

Supplier Access for Regenerative Health Clinics: Why the Vendor Relationships You Have on Day One Determine Your Margins for Years

Supplier Access for Regenerative Health Clinics: Why the Vendor Relationships You Have on Day One Determine Your Margins for YearsNova S.
Published on: 09/07/2026

Regenerative health clinic supplier access and vendor connections in 2026 — compounding pharmacies, regenerative materials, equipment, lab partners, and how pre-negotiated pricing affects clinic economics.

regenerative health clinic supplier accessregenerative clinic vendor accesscompounding pharmacy clinic supplierclinic supplier pricingpeptide clinic vendor connectionshormone clinic supplier network 2026compounding pharmacy preferred pricingregenerative clinic vendor networkclinic equipment supplier accessexosome vendor cliniclab partner clinic pricinghow to find suppliers for a regenerative health clinicbest compounding pharmacy for a clinicregenerative clinic vendor pricing and access
Read more
Built by operators. Proven across hundreds of clinic launches.

A leading regenerative health clinic consulting firm. We help entrepreneurs open Regenerative Health, Longevity, and MedSpa clinics, hundreds launched and optimized, no medical background required.

Clinics Supported Nationwide
Serving Entrepreneurs Across All 50 States
No Medical Background Required
One-Time Fee. No Royalties
60 Days to Open. From Keys to First Patient*

© 2026 Altos Consulting Group. All rights reserved.

Altos Consulting Group is a business consulting and advisory firm. ACG is not a medical practice and does not provide medical care, diagnose, prescribe, dispense, or manufacture any drug, biologic, device, or therapy. At every clinic we support, all clinical and treatment decisions are made by independent, state-licensed medical providers who own and direct patient care, consistent with applicable Corporate Practice of Medicine laws. Regenerative and cash-pay therapies, including PRP, peptides, GLP-1 medications, and exosome or cellular products, are subject to federal and state regulation, and not all products or uses are FDA-approved or cleared; the FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease. Clinic owners are responsible for ensuring their products, therapies, and marketing comply with all FDA, FTC, state medical board, and state advertising requirements. Any results, revenue figures, or timelines shown are illustrative, reflect specific clients under specific conditions, are not typical, and are not guarantees of income or success; individual outcomes vary by market, location, capital, regulatory conditions, and operator execution. ACG partners with vetted lending providers to help clients access capital and does not act as a lender. The "60 days to open" reference is a target, not a guarantee, and varies by state, market, and regulatory conditions. FTC Disclaimer: results described in testimonials and case studies are not typical, and individual results will vary. © 2026 Altos Consulting Group.